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What is the Goal of Fluid Management 
“Optimization”?
Giorgio Della Rocca, Luigi Vetrugno
University of Udine, Department of Medical and Biological Sciences, Udine, Italy
The debate about fluid management in the operating room is still far from reaching a unanimous conclusion (1-3). However, the concept that fluid administration holds the potential to worsen or improve 
patient outcome is generally accepted as true and in the last decade the con-
cept that “zero-balance” has overtaken other classical approaches, including 
the liberal fluid strategy or Goal-Directed-Therapy (GDT) (4, 5).
The origins of this peaceful ‘revolution’ can be traced back to the work of 
Brandstrup et al. (6), which raised questions about the standard clinical prac-
tices in use at the time. They showed that fluid administration during major 
colon-rectal surgery was associated with perioperative weight gain and an 
increased risk of complications. In other words, because of excessive fluid ad-
ministration during surgery, patients were gaining too much weight: Periop-
erative weight gain indicates that the fluids given exceeded fluid losses.
Even after prolonged pre-operative fasting, healthy patients remain euvole-
mic (7). In addition, insensible perspiration during the perioperative peri-
od has been re-evaluated, as reported in the study by Lamke et al., (8) since 
baseline evaporation during large abdominal surgery was shown to be approx-
imately 0.5 to 1 mL/kg/h. Finally, definitive evidence has come to light indi-
cating that the ‘third space’ does not exist and therefore does not need to be 
replaced (9).
Fluid retention is a normal neuro-hormonal response to surgery and per-
missive oliguria less than 0.5 mL/kg/h for up 2-4 hours should be accepted 
(10-12). The link between maintaning body weight and perioperative in-
travenous fluid administration is currently associated with a lower risk of 
complications following abdominal surgery (13).
The fluid regimen illustrated by Brandstrup et al. (6) aimed to achieve ze-
ro-balance, i.e. zero gain in body weight; this non-restricted, non-liberal flu-
id approach was mainly performed in American Society of Anesthesiology 
(ASA) 1, 2 patients. Brandstrup’s results are also supported by the Enhanced 
Recovery After Surgery (ERAS) programme in which, of the 20 variables 
evaluated by multiple regression analysis, fluid management represents the 
major independent predictive factor of postoperative outcome, together with 
preoperative carbohydrate administration (14).
It has also been shown that for each additional litre of fluids given in the op-
erating room, there is a 16% increase in the risk of postoperative symptoms 
and a 32% increase in the probability of postoperative complications (14). 
In the United States, where the ERAS principles are not widely accepted or 
implemented, high fluid volume given on the day of surgery has also been 
associated with increased length of stay (LOS) and increased costs (15): An-
esthesiologist practices can make the difference.
What is the Target of “Optimization” of the Fluid Management?     
DELLA ROCCA vs. LICKER First Round
DEBATE
“Fluid management” (FM) is a complicated, unsolved 
riddle. I think we should first find the “good questions”; 
or rather, we have to formulate the questions in an ap-
propriate way. Otherwise, it may the case that you com-
pare “liberal” (?) vs ”restrictive” (?) strategies; and find 
at the end that you have given even more fluid in the 
restrictive group because of the “rescue”. Not to mention 
is that what you call “liberal” in some studies is defined 
in some other studies as “restrictive”. 
Now we have a third way: “optimised FM”. It sounds 
and seems to be rational, but are there also some lim-
itations or drawbacks of this approach? Or rather: “Can 
optimal FM be really optimal?”.
Let me expand my question with further questions: 
Some authors advocate that being restrictive is optimal 
to avoid edema, whereas others defend that FM should 
not cost AKI (acute kidney injury). Is “optimal FM” 
indeed a peak between “hypovolemia” and “hypervole-
mia” (curve A); or is the FM curve maybe an irregular, 
fluctuant curve with several peaks, maybe “u”-shaped 
instead of “v”? (curve B).
In those terms, I want you to remind the keyword “gly-
cocalyx”. With increasing information about glycocalyx, 
we recognize that we have to revise all the knowledge we 
have, such as Frank-Starling Curve.
My last question is a stupid one: what is actually the 














On the other hand, assessing “normovolemia” is quite difficult; the 
problem is that not only hypovolemia but also hypervolemia  has 
been associated with a ‘restrictive’ approach.
However, there are no clear indications to what a “liberal approach” 
actually means compared with a “restricted” one in terms of mL/
kg/h and the type of fluid that should be given (5, 16). Fluids can be 
administered in the form of fluid maintenance or a fluid challenge 
(FC); except in the case that a patient continues to lose blood, when 
the volume of fluids administered are deemed to be sufficient, cur-
rent research indicates that fluid administration should be suspended 
and vasopressor infusion commenced until an “acceptable systemic 
blood pressure” is reached. As stated before, one of the most import-
ant recent changes in clinical practice has been in the management of 
“fluid maintenance”. The concept of FC remains the same (17): a FC 
constitutes a test that allows the clinician to understand whether the 
patient is on the Franc-Starling curve and whether he has a preload 
reserve that can be used to increase the stoke volume (SV) and cardi-
ac output (CO). In the case of a positive response, additional FC can 
be given if required. In the case of a negative response, further FC 
should be avoided and the only extra fluid given to the patient should 
be that administered if the patient fails to respond; this volume is 
usually equal to or no more than 200 mL or 3 mL/kg (17). This ap-
proach forms the basis of most GDT algorithms that aim to optimize 
tissue perfusion by maximizing oxygen delivery (DO2).
Esophageal Doppler (ED) monitoring and its related flow algo-
rithm is the most common tool cited in the literature used to per-
form GDT. ED has been recommended as a routine monitoring 
system for abdominal surgery in the UK (18) and France (19) and 
endorsed by Medicare and the Medicaid Service in the USA (20).
Compared with the liberal fluid approach, GDT is superior in 
terms of risk of postoperative complication, in selected popu-
lation
Hamilton et al. (21) reported that over the last 10 years the mor-
tality rate of patients not receiving GDT (compared with those 
who did receive GDT) was significantly lower (7% compared with 
13.5%, respectively), probably due to improvements made in sur-
gical and anesthetic practices.
In order to demonstrate a 2% difference in mortality rate between 
patients receiving GDT and control patients (no GDT), a study 
would need to be conducted involving at least 2312 patients per 
group. No such study has been published to date.
A meta-analysis study by Cochrane (22) concluded: “The balance of 
current evidence does not support widespread implementation of this 
approach to reduce mortality but does suggest that complications and 
duration of hospital stay are reduced”. The study considered 24 studies 
with a combined total of 2677 patients and revealed a p<0.02 for 
mortality in elective surgery. Moreover, it suggests that the use of 
GDT reduced the rate of three morbidities: renal failure, respirato-
ry failure and wound infection.
GDT decreases risk of complications during the first 30 post-
operative days and may improve long term outcome, in selected 
population
A study known as the OPTIMIZE study (23) enrolled the largest 
population of high-risk patients ever achieved to date and com-
pared the GDT with usual care. This study showed a strong trend 
for patients receiving GDT to experience fewer complications 
in the first 30 postoperative days (36.6%) than control patients 
(43.4%), although the difference did not quite achieve statistical 
significance (p=0.07). However, more than 50% of the patients in 
this study were ASA 1-2 undergoing elective surgery. The calculat-
ed sample size was based on a much higher expected incidence of 
postoperative complications (50% higher), leaving the study with-
out the power to show potential differences (24).
How can we interpret this evidence into a take home message? The 
majority of the available studies in literature published before 2006 
compared GDT with a liberal approach to fluid administration in 
patients who were mainly ASA 1 or 2, and generated results in 
favour of GDT (25). Later studies that compared GDT with a re-
stricted approach or ERAS programme showed no differences, and 
again mainly concerned ASA 1 or ASA 2 patients (26, 27).
We know that the risk of adverse events during and after surgery is 
increased in patients with limited cardiovascular and/or respiratory 
reserve. From the ethical standpoint, research into invasive hemo-
dynamic monitoring and fluid management cannot be performed 
in healthy patients, as such techniques can only be justified in sick-
er and higher risk patients (28). We also know that the type of 
surgery (low-intermediate versus high risk) can make the difference 
(29). Considering these facts, we can conclude that:
1) The best patients to study should comprise high risk surgi-
cal patients ASA 3 and 4;
2) Cardiac output monitoring should also be applied to the 
appropriate types of surgery;
3) Maintenance fluid administration should be no more than 
1-3 mL/kg/h;
4) A GDT approach should be an “active” approach, the aim 
of which is not to “maximize” but to “optimize” the goal 
only in patients classified as fluid responders;
5) …. goals should be maintained for up to 6-8 postoperative 
hours. 
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